Bacterial News and Research

RSS

Pneumococcal vaccine reduces the incidence of middle ear infection and pneumonia

Infection with Streptococcus pneumoniae bacteria can cause serious illness and death. Invasive pneumococcal disease is responsible for about 200 deaths each year among children under 5 years old.

8 Sep 2004

New way of killing dangerous bacteria like the ones which cause anthrax and pneumonia

The new bug-smashing technique uses the bacteria’s own natural enemies, tiny viruses called bacteriophages (or phages), which can infect bacterial cells. The phages make thousands of copies of themselves inside infected bacteria, but then need to dissolve the bacteria’s cell wall to get out and infect other bacterial cells.

7 Sep 2004

Bee stings may provide a solution to overcome MRSA superbugs

Bee stings may provide a solution to overcome the growing problem of antibiotic resistance in bacteria according to new research presented Monday by Belfast scientists at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.

7 Sep 2004

Phico Therapeutics secures funding to tackle superbug

Phico Therapeutics Ltd, a Cambridge-based company that has developed a unique anti-bacterial technology to treat the hospital superbug, MRSA, has raised £550,000 with the help of Oxfordshire Investment Opportunity Network, Europe’s leading technology business angel network.

6 Sep 2004

International research sheds light on Escherichia coli

An unprecedented picture of how bacteria latch on to human cells has been published by UK, French and US scientists. They have produced a finely detailed model of one of the tools used by some of the nastiest varieties of the stomach bug, Escherichia coli, to stick to and gain entry to host cells.

1 Sep 2004

Flaw in DNA helps explain cancers and aging

Their finding explains how oxidative DNA damage - a process long believed to underlie cancers and aging - can create permanent genetic damage.

30 Aug 2004

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered.

30 Aug 2004

Streptococcal bacteria disrupts blood clotting to infect humans

University of Michigan researchers have captured a glimpse of the endless arms race between infectious agents and the human immune system in a bacterium that uses a mimic of a human blood-clotting enzyme to advance its infection.

27 Aug 2004

Stress won't cause stomach ulcers, but it can make them worse

“Stress won't cause stomach ulcers, but it can make them worse,” says Dr. David Graham, professor of medicine and molecular virology and microbiology at Baylor College of Medicine. “Stress causes the body to produce higher amounts of acid, which can irritate preexisting ulcers.”

27 Aug 2004

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Young adults who attended day care or nursery school when they were children were more than a third less likely to develop Hodgkin's disease, according to a new study by Harvard School of Public Health researchers.

25 Aug 2004

Diarrhea the leading cause of death among the developing world's children

To most people in the developed world, diarrhea is a nuisance. It means some discomfort and maybe a trip to the local pharmacy.

23 Aug 2004

Rooms where people smoke contain higher air concentrations of endotoxins

A room where people smoke contains dozens or hundreds of times higher air concentrations of endotoxins than smoke-free indoor air. This has been shown by a research team from Lund University.

23 Aug 2004

Pineal gland which regulates the cycles of sleep and waking evolved to improve vision

The pineal gland - which regulates the cycles of sleep and waking - appears to have evolved as an indirect way to improve vision, by keeping toxic compounds away from the eye

13 Aug 2004

Ways to economically recover recombinant proteins from transgenic tobacco

The economics of producing biopharmaceuticals from transgenic plants such as tobacco is still a roadblock to producing large quantities of urgently needed medicines, especially for people in underdeveloped nations.

12 Aug 2004

Microscopic scaffolding to house the tiny components of nanotech devices could be built from RNA

Microscopic scaffolding to house the tiny components of nanotech devices could be built from RNA, the same substance that shuttles messages around a cell's nucleus, reports a Purdue University research group.

12 Aug 2004

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device Directive (MDD) and EU regulations.

11 Aug 2004

Hospital anti-infection strategy probably won't work

Hospital patients increasingly face tenacious bacterial infections because microbes found in hospitals acquire resistance to commonly prescribed antibiotics. A recent strategy alternating the most commonly used antibiotics has sparked hope of stopping the spread of antibiotic resistance.

9 Aug 2004

First evidence of the molecular link between inflammation and cancer

The investigators found that a gene called I-kappa-B kinase (IKK beta), a pro-inflammatory gene, acts differently in two cell types to cause cancer. When IKK beta was deleted, the cancer incidence and tumor growth in mice was decreased by nearly 80 percent.

5 Aug 2004

Potential of genomics in disease research yet to be realized

Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

5 Aug 2004

Blood vessel plug - amplatzer ductal occluder, performs well in trial

In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.

5 Aug 2004

Bacterial News and Research

Pneumococcal vaccine reduces the incidence of middle ear infection and pneumonia

New way of killing dangerous bacteria like the ones which cause anthrax and pneumonia

Bee stings may provide a solution to overcome MRSA superbugs

Phico Therapeutics secures funding to tackle superbug

International research sheds light on Escherichia coli

Flaw in DNA helps explain cancers and aging

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

Streptococcal bacteria disrupts blood clotting to infect humans

Stress won't cause stomach ulcers, but it can make them worse

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Diarrhea the leading cause of death among the developing world's children

Rooms where people smoke contain higher air concentrations of endotoxins

Pineal gland which regulates the cycles of sleep and waking evolved to improve vision

Ways to economically recover recombinant proteins from transgenic tobacco

Microscopic scaffolding to house the tiny components of nanotech devices could be built from RNA

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

Hospital anti-infection strategy probably won't work

First evidence of the molecular link between inflammation and cancer

Potential of genomics in disease research yet to be realized

Blood vessel plug - amplatzer ductal occluder, performs well in trial

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News